Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydroxychloroquine 22mg/5ml oral solution
1001030C0AAAUAU
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 250mg/5ml oral solution
1001030C0AABEBE
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 25mg/5ml oral solution
1001030C0AAASAS
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 30mg/5ml oral solution
1001030C0AAAMAM
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 36mg/5ml oral solution
1001030C0AABFBF
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 400mg/5ml oral solution
1001030C0AAAWAW
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 400mg/5ml oral suspension
1001030C0AABLBL
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 40mg/5ml oral solution
1001030C0AAAHAH
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 53.33mg/5ml oral solution
1001030C0AABDBD
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 60mg/5ml oral solution
1001030C0AAALAL
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 65mg/5ml oral solution
1001030C0AAAQAQ
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 70mg/5ml oral solution
1001030C0AAAZAZ
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 75mg/5ml oral liquid
1001030C0AAAGAG
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 80mg/5ml oral solution
1001030C0AABHBH
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 85mg/5ml oral solution
1001030C0AAAYAY
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxyethyl salicylate 6% / Methyl nicotinate 1.6% spray
1003020N0AAAZAZ
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.4ml inj pre-filled syringes
1001030S0BEADAE
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.4ml solution for injection pre-filled pens
1001030S0BEACAD
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.8ml inj pre-filled syringes
1001030S0BEABAA
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Ibucalm Ibuprofen Pain Relief 5% gel
1003020P0BUAAAC
|
Ibucalm (Topical Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuderm 5% gel
1003020P0BTAAAC
|
Ibuderm | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibufem 200mg tablets
1001010J0CHAAAD
|
Ibufem | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 200mg tablets
1001010J0DJAAAD
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 400mg tablets
1001010J0DJABAE
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve 5% Mousse
1003020P0BCAEAF
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.